opaganib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

RedHill Biopharma Limited (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadpneumonia

I am/have/hadx-rays

I am/have/hadchest x-ray

I am/have/hadoropharyngeal

I am/have/hadcovid-19

I am/have/hadcoronavirus infection

added new label for I am/have/had

more

I am looking for

I am looking forx-rays

I am looking foropaganib

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

Opaganib, a sphingosine kinase-2 (SphK2) inhibitor, has been broadly tested in Phase I/II studies. Extensive nonclinical data indicates both anti-viral and anti-inflammatory activity via selective SphK2 inhibition which may prove beneficial for treating COVID-19 infection and resulting pneumonia.

pneumonia

x-rays

chest x-ray

oropharyngeal

covid-19

0 views
16 Feb, 2024
5 locations

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.